Suchergebnisse - "Rahier, J-F"

PubPharm (6)

1

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease : Results from the Multicenter European TEDDY Study

enthalten in: The American journal of gastroenterology | 2018

von Chaparro, M. | Verreth, A. | Lobaton, T. | +61

CommentIn: Am J Gastroenterol. 2018 Dec;113(12):1903. - PMID 29895982

2

Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD) : position document of the Belgian IBD Research & Development Group (BIRD)

enthalten in: Acta gastro-enterologica Belgica | 2015

von Vermeire, S. | Louis, E. | Dewit, O. | +9

3

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

enthalten in: Journal of Crohn's & colitis | 2013

von Baert, F. | Glorieus, E. | Reenaers, C. | +57

4

Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease

enthalten in: Acta gastro-enterologica Belgica | 2012

von De Greef, E. | Hoffman, I. | D'Haens, G. | +20

5

The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab

enthalten in: Alimentary pharmacology & therapeutics | 2011

von Kopylov, U. | Mantzaris, G. | Katsanos, K. | +10

6

Regression of Sweet's syndrome associated with Crohn's disease after anti-Tumour Necrosis Factor therapy

enthalten in: Acta gastro-enterologica Belgica | 2005

von Rahier, J. | Lion, L. | Dewit, O. | +1

1
[1]